Pharma firm Procter & Gamble Health Friday reported a 79.21 per cent rise in its net profit to Rs 40.70 crore for the first quarter ended March 2019, driven by high interest income and operational efficiencies.
The company had posted a net profit of Rs 22.71 crore for the corresponding period of the previous fiscal, Procter & Gamble Health said in a filing to the BSE.
Total income of the company stood at Rs 248.72 crore for the quarter under consideration. It was Rs 203.54 crore for the same period a year ago.
"With a brand portfolio backed by science and trusted by doctors, pharmacists and consumers, and the best of consumer health capabilities and cultures, we are working towards creating a much stronger presence in India's fast-growing consumer health industry," Procter & Gamble Health Ltd MD Milind Thatte said.
Procter & Gamble Health (formerly Merck Ltd) manufactures and markets over-the-counter products, vitamins, minerals, and supplements products.
Shares of the company closed at Rs 3,707.25 per scrip on the BSE, up 0.33 per cent from the previous close.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)